FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

787994008: Antibacterial therapeutic role (role)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3778326014 Antibacterial therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3778327017 Antibacterial therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module


3 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antibacterial therapeutic role Is a Therapeutic role false Inferred relationship Existential restriction modifier
Antibacterial therapeutic role Is a Antiinfective therapeutic role true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely dicloxacillin sodium 250 milligram/1 each conventional release oral capsule Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dicloxacillin sodium 500 milligram/1 each conventional release oral capsule Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely doxycycline hyclate 50 milligram/1 each conventional release oral capsule Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely doxycycline hyclate 100 milligram/1 each conventional release oral capsule Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely azithromycin dihydrate 250 milligram/1 each conventional release oral tablet Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely azithromycin dihydrate 600 milligram/1 each conventional release oral tablet Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely grepafloxacin 400 milligram/1 each conventional release oral tablet Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely grepafloxacin 600 milligram/1 each conventional release oral tablet Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tetracycline hydrochloride 500 milligram/1 each conventional release oral capsule Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefdinir 300 milligram/1 each conventional release oral capsule Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin ethylsuccinate 400 milligram/1 each conventional release oral tablet Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cinoxacin 250 milligram/1 each conventional release oral capsule Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefadroxil 1 gram/1 each conventional release oral tablet Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methenamine hippurate 1 gram/1 each conventional release oral capsule Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cinoxacin 500 milligram/1 each conventional release oral capsule Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime axetil 250 milligram/1 each conventional release oral tablet Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime axetil 500 milligram/1 each conventional release oral tablet Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime axetil 125 milligram/1 each conventional release oral tablet Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime axetil 300 milligram/1 each conventional release oral tablet Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime axetil 601.44 milligram/1 each conventional release oral tablet Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely doxycycline monohydrate 50 milligram/1 each conventional release oral capsule Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nitrofurantoin macrocrystal 25 milligram and nitrofurantoin monohydrate 75 milligram/1 each conventional release oral capsule Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin (as amoxicillin trihydrate) 80 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 11.4 milligram/1 milliliter conventional release oral suspension Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bacitracin 500 unit/1 gram conventional release cutaneous ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bacitracin 500 unit/1 gram conventional release eye ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 250 milligram and imipenem anhydrous (as imipenem) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefotetan (as cefotetan disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime axetil) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefdinir 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefepime (as cefepime hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftibuten 18 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftibuten 36 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely piperacillin (as piperacillin sodium) 3 gram and tazobactam (as tazobactam sodium) 375 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 125 milligram and clavulanic acid (as clavulanate potassium) 31.2 milligram/1 each conventional release chewable tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ampicillin (as ampicillin sodium) 125 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ampicillin (as ampicillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ampicillin (as ampicillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ampicillin (as ampicillin sodium) 1 gram and sulbactam (as sulbactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ampicillin (as ampicillin sodium) 2 gram and sulbactam (as sulbactam sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely chloramphenicol 5 milligram/1 milliliter conventional release ear solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 333 milligram/1 each gastro-resistant oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin estolate 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nitrofural 2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tetracycline 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfanilamide 1.05 gram/1 each conventional release vaginal pessary (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfafurazole 40 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely doxycycline calcium 5 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely minocycline 10 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methenamine mandelate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely metronidazole 7.5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefpodoxime 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely oxacillin (as oxacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely oxacillin (as oxacillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nafcillin (as nafcillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nafcillin (as nafcillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 125 milligram/1 each conventional release chewable tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benzylpenicillin potassium 250000 unit/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benzylpenicillin potassium 400000 unit/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely doxycycline hyclate 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely chloramphenicol (as chloramphenicol sodium succinate) 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nalidixic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin estolate 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 100 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefradine 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tobramycin 3 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tobramycin 3 milligram/1 gram conventional release eye ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 gram conventional release eye ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 15 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release ear solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfacetamide sodium 150 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftriaxone (as ceftriaxone sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 500 milligram/1 each gastro-resistant oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefprozil 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely prednisolone acetate 2 milligram/1 gram and sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely prednisolone acetate 2.5 milligram/1 gram and sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefradine 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release vaginal cream (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefaclor 125 milligram/1 each conventional release chewable tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefaclor 187 milligram/1 each conventional release chewable tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefaclor 375 milligram/1 each conventional release chewable tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely gentamicin sulfate 3 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefdinir 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely metronidazole 10 milligram/1 gram conventional release cutaneous gel (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely gatifloxacin 40 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 6 of 27 Next End


This concept is not in any reference sets

Back to Start